[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569250":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":55,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":26,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":26,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":81,"overallStatus":85,"whyStopped":26,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Henan University of Traditional Chinese Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Shu Fei Tie group for Asthma\u002FCOPD","EXPERIMENTAL","Patients in the Asthma\u002FCOPD experimental group were treated with Shu Fei Tie",[13],"Drug: Shu Fei Tie",{"label":15,"type":16,"description":17,"interventionNames":18},"Shu Fei Tie Placebo group for Asthma\u002FCOPD","PLACEBO_COMPARATOR","Patients in the Asthma\u002FCOPD experimental group were treated with Shu Fei Tie Placebo",[19],"Drug: Shu Fei Tie placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Shu Fei Tie","Optimize the extraction process and matrix formulation, and combine the use of traditional Chinese medicine volatile oil and chemical transdermal enhancers to develop adermal patch（Shu Fei Tie）",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Shu Fei Tie placebo","Shu Fei Tie Placebos are made using substances without active drug ingredients, following the same preparation procedures",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"suyun Li PhD","CONTACT","13938415502","lisuyun2000@126.com",[38],{"facility":39,"status":26,"city":40,"state":41,"zip":26,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"The First Affiliated Hospital of Henan University of Chinese Medicine","Zhengzhou","Henan","China","CN",{"type":45,"coordinates":46},"Point",[47,48],113.64861,34.75778,{"lat":48,"lon":47},[51],{"name":52,"role":34,"phone":35,"phoneExt":26,"email":36},"Suyun Li PhD",{"type":54,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[56,59],{"name":57,"class":58},"Qingdao Municipal Hospital of Traditional Chinese Medicine","UNKNOWN",{"name":60,"class":58},"Henan Lingrui Pharmaceutical Co., Ltd","100569250","clinical-study-on-the-treatment-of-chronic-airway-diseases-asthma-chronic-obstructive-pulmonary-disease-with-shu-fei-tie-100569250",false,"NCT06691802","Clinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie","Clinical Study on Reducing Recurrent Attacks of Chronic Airway Diseases (asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie Based on \"winter Disease Being Cared in Summer\"","Inclusion Criteria:\n\n* Meets the diagnostic criteria for asthma\u002FCOPD(Group E in the GOLD classification); ② Age range from18 years to 80 years(asthma) and 40 yesrs to 80 years(COPD);\n\n  * The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.\n\nExclusion Criteria:\n\n* Patients with other pulmonary diseases (lung abscess, pulmonary interstitial fibrosis, active pulmonary tuberculosis, bronchiectasis，etc);\n\n  * Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina, acute myocardial infarction, heart grade 3 or above, stroke, cerebral hemorrhage, etc.);\n\n    * Patients with severe liver diseases (liver cirrhosis, portal hypertension, and caused by esophageal and gastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.);\n\n      * Patients with impaired consciousness or various illnesses who cannot communicate normally; ⑤Pregnant and lactating women; ⑥Patients who are participating in other clinical trials within one month prior to enrollment; ⑦Patients who have received acupuncture or other traditional Chinese medicine external treatments within the past year; ⑧ Patients who are allergic to external patches","ALL","18 Years","80 Years",{"count":72,"type":73},2312,"ESTIMATED","INTERVENTIONAL",[76],"NA","Conduct a multi-center, large-sample, randomized controlled clinical study of \"winter disease being cared in summer\" with Shu Fei Tie prevent recurrence of Asthma and COPD, scientifically evaluate the clinical efficacy and safety of Shu Fei Tie in reducing the recurrence of chronic airway diseases, identify target population, clarify the mechanism of efficacy, and establish a prevention and treatment technology plan for Shu Fei Tie to reduce the recurrence of chronic airway diseases.",[79,80],"Chronic Obstructive Pulmoriary Disease (COPD)","Asthma",[82,80,23,83,84],"Chronic Obstructive Pulmoriary Disease","Winter disease being cared in summer","Randomized Controlled Trial","NOT_YET_RECRUITING","2024-11-14",{"date":88,"type":89},"2024-11-15","ACTUAL",{"date":91,"type":73},"2024-12",{"date":93,"type":73},"2028-07",{"name":5,"class":6},1]